Maulana, Basir W.

HRN: 25-23-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/13/2025
CEFTAZIDIME 1GM (VIAL)
06/13/2025
06/20/2025
IV
1g
Q8h
Pulmonary Fibrosis R/o PTB Retreatment After Lost To Followup
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines